Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Favrot

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Gene Therapy|February 1, 1997
In vitro targeting and specific transfection of human neuroblastoma cells by chCE7 antibody-mediated gene transferJ L Coll, E Wagner, V Combaret, et al.
Cancer Research|April 15, 1990
Correlation between clinical response to interleukin 2 therapy and sustained production of tumor necrosis factorJ Y Blay, M C Favrot, S Negrier, et al.
International Journal of Cancer|June 19, 1991
Expression of leucocyte adhesion molecules on 66 clinical neuroblastoma specimensM C Favrot, V Combaret, E Goillot, et al.
International Journal of Cancer|September 30, 1991
Expression of integrin receptors on 45 clinical neuroblastoma specimensM C Favrot, V Combaret, E Goillot, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1989
Clinical value of N-myc oncogene amplification in 52 patients with neuroblastoma included in recent therapeutic protocolsV Combaret, Q Wang, M C Favrot, et al.
British Journal of Cancer|October 1, 1986
Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrowM C Favrot, D Frappaz, O Maritaz, et al.
British Journal of Cancer|January 1, 1997
Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expressionV Combaret, N Gross, C Lasset, et al.
Journal of Biological Response Modifiers|April 1, 1990
Functional and immunophenotypic modifications induced by interleukin-2 did not predict response to therapy in patients with renal cell carcinomaM C Favrot, V Combaret, S Negrier, et al.
Pediatric Hematology and Oncology|January 1, 1990
Interleukin 2 immunotherapy in children with neuroblastoma after high-dose chemotherapy and autologous bone marrow transplantationM C Favrot, J Michon, D Floret, et al.
British Journal of Cancer|June 1, 1989
Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantationV Combaret, M C Favrot, B Kremens, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Gene Therapy|February 1, 1997
In vitro targeting and specific transfection of human neuroblastoma cells by chCE7 antibody-mediated gene transferJ L Coll, E Wagner, V Combaret, et al.
Cancer Research|April 15, 1990
Correlation between clinical response to interleukin 2 therapy and sustained production of tumor necrosis factorJ Y Blay, M C Favrot, S Negrier, et al.
International Journal of Cancer|June 19, 1991
Expression of leucocyte adhesion molecules on 66 clinical neuroblastoma specimensM C Favrot, V Combaret, E Goillot, et al.
International Journal of Cancer|September 30, 1991
Expression of integrin receptors on 45 clinical neuroblastoma specimensM C Favrot, V Combaret, E Goillot, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1989
Clinical value of N-myc oncogene amplification in 52 patients with neuroblastoma included in recent therapeutic protocolsV Combaret, Q Wang, M C Favrot, et al.
British Journal of Cancer|October 1, 1986
Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrowM C Favrot, D Frappaz, O Maritaz, et al.
British Journal of Cancer|January 1, 1997
Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expressionV Combaret, N Gross, C Lasset, et al.
Journal of Biological Response Modifiers|April 1, 1990
Functional and immunophenotypic modifications induced by interleukin-2 did not predict response to therapy in patients with renal cell carcinomaM C Favrot, V Combaret, S Negrier, et al.
Pediatric Hematology and Oncology|January 1, 1990
Interleukin 2 immunotherapy in children with neuroblastoma after high-dose chemotherapy and autologous bone marrow transplantationM C Favrot, J Michon, D Floret, et al.
British Journal of Cancer|June 1, 1989
Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantationV Combaret, M C Favrot, B Kremens, et al.
Pageof 8